These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 9407422

  • 1. Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
    Ruggenenti P, Perna A, Mosconi L, Matalone M, Pisoni R, Gaspari F, Remuzzi G.
    Kidney Int Suppl; 1997 Dec; 63():S54-7. PubMed ID: 9407422
    [Abstract] [Full Text] [Related]

  • 2. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
    Ruggenenti P, Perna A, Mosconi L, Pisoni R, Remuzzi G.
    Kidney Int; 1998 May; 53(5):1209-16. PubMed ID: 9573535
    [Abstract] [Full Text] [Related]

  • 3. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun 28; 349(9069):1857-63. PubMed ID: 9217756
    [Abstract] [Full Text] [Related]

  • 4. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy.
    Ruggenenti P, Perna A, Gherardi G, Gaspari F, Benini R, Remuzzi G.
    Lancet; 1998 Oct 17; 352(9136):1252-6. PubMed ID: 9788454
    [Abstract] [Full Text] [Related]

  • 5. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ, Petersen JR, Talleruphuus U, Møller ML, Ladefoged SD, Mehlsen J, Jensen HA.
    Clin Nephrol; 2001 May 17; 55(5):375-83. PubMed ID: 11393383
    [Abstract] [Full Text] [Related]

  • 6. Retarding progression of chronic renal disease: the neglected issue of residual proteinuria.
    Ruggenenti P, Perna A, Remuzzi G, GISEN Group Investigators.
    Kidney Int; 2003 Jun 17; 63(6):2254-61. PubMed ID: 12753315
    [Abstract] [Full Text] [Related]

  • 7. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.
    Clin Exp Hypertens; 2005 Jun 17; 27(2-3):129-38. PubMed ID: 15835375
    [Abstract] [Full Text] [Related]

  • 8. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria.
    Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, Scolari F, Schena FP, Remuzzi G.
    Lancet; 1999 Jul 31; 354(9176):359-64. PubMed ID: 10437863
    [Abstract] [Full Text] [Related]

  • 9. Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?
    van Essen GG, Apperloo AJ, Rensma PL, Stegeman CA, Sluiter WJ, de Zeeuw D, de Jong PE.
    Kidney Int Suppl; 1997 Dec 31; 63():S58-62. PubMed ID: 9407423
    [Abstract] [Full Text] [Related]

  • 10. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM, Aboudara MC, Uy AL, Olson SW, Cushner HM, Yuan CM.
    Am J Kidney Dis; 2009 Apr 31; 53(4):606-16. PubMed ID: 19216016
    [Abstract] [Full Text] [Related]

  • 11. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
    Clin Ther; 2008 Mar 31; 30(3):482-98. PubMed ID: 18405787
    [Abstract] [Full Text] [Related]

  • 12. Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.
    Pisoni R, Faraone R, Ruggenent P, Remuzzi G.
    J Nephrol; 2002 Mar 31; 15(4):428-30. PubMed ID: 12243375
    [Abstract] [Full Text] [Related]

  • 13. In chronic nephropathies prolonged ACE inhibition can induce remission: dynamics of time-dependent changes in GFR. Investigators of the GISEN Group. Gruppo Italiano Studi Epidemiologici in Nefrologia.
    Ruggenenti P, Perna A, Benini R, Bertani T, Zoccali C, Maggiore Q, Salvadori M, Remuzzi G.
    J Am Soc Nephrol; 1999 May 31; 10(5):997-1006. PubMed ID: 10232685
    [Abstract] [Full Text] [Related]

  • 14. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes.
    Imbasciati E, Gregorini G, Cabiddu G, Gammaro L, Ambroso G, Del Giudice A, Ravani P.
    Am J Kidney Dis; 2007 Jun 31; 49(6):753-62. PubMed ID: 17533018
    [Abstract] [Full Text] [Related]

  • 15. Progression rate to end-stage renal failure in non-diabetic kidney diseases: a multivariate analysis of determinant factors.
    Jungers P, Hannedouche T, Itakura Y, Albouze G, Descamps-Latscha B, Man NK.
    Nephrol Dial Transplant; 1995 Jun 31; 10(8):1353-60. PubMed ID: 8538926
    [Abstract] [Full Text] [Related]

  • 16. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.
    Jones C, Roderick P, Harris S, Rogerson M.
    Nephrol Dial Transplant; 2006 Aug 31; 21(8):2133-43. PubMed ID: 16644779
    [Abstract] [Full Text] [Related]

  • 17. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study.
    Imai E, Horio M, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Makino H, Hishida A, Matsuo S.
    Hypertens Res; 2008 Mar 31; 31(3):433-41. PubMed ID: 18497462
    [Abstract] [Full Text] [Related]

  • 18. Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen).
    Ruggenenti P, Perna A, Zoccali C, Gherardi G, Benini R, Testa A, Remuzzi G.
    J Am Soc Nephrol; 2000 Jan 31; 11(1):88-96. PubMed ID: 10616844
    [Abstract] [Full Text] [Related]

  • 19. No clear evidence of ACEi efficacy on the progression of chronic kidney disease in children with hypodysplastic nephropathy--report from the ItalKid Project database.
    Ardissino G, Viganò S, Testa S, Daccò V, Paglialonga F, Leoni A, Belingheri M, Avolio L, Ciofani A, Claris-Appiani A, Cusi D, Edefonti A, Ammenti A, Cecconi M, Fede C, Ghio L, La Manna A, Maringhini S, Papalia T, Pela I, Pisanello L, Ratsch IM, ItalKid Project.
    Nephrol Dial Transplant; 2007 Sep 31; 22(9):2525-30. PubMed ID: 17526542
    [Abstract] [Full Text] [Related]

  • 20. Late outcome of a controlled trial of enalapril treatment in progressive chronic renal failure. Hard end-points and influence of proteinuria.
    Kamper AL, Strandgaard S, Leyssac PP.
    Nephrol Dial Transplant; 1995 Sep 31; 10(7):1182-8. PubMed ID: 7478121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.